Moderna vaccine trial to boost economy and jobs

ESRI research professor Kieran McQuinn says the latest successful Covid vaccine trial could save thousands of jobs over Christmas

The EU is likely to order 160 million doses of the Moderna vaccine for member states. File image

A second hugely successful trial for a new vaccine for Covid-19 has the potential to transform the battered Irish economy and save thousands of jobs over Christmas, research professor Kieran McQuinn at the ESRI has predicted.

The boost came after US-based Moderna revealed its vaccine trial of 30,000 people showed a success rate of 94.5%, bettering even the outstanding performance of Pfizer and Germany’s BioNTech last week.